Longitudinal Assessment of Circulating Tumor Cells and Outcome in Small Cell Lung Cancer: A Sub-Study of RASTEN—A Randomized Trial with Low Molecular Weight Heparin

SIMPLE SUMMARY: Small cell lung cancer (SCLC) is an aggressive lung cancer subtype associated with an overall poor prognosis but a variable response rate to chemotherapy. The measurement of circulating tumor cells (CTCs) offers a non-invasive method to monitor the disease and may provide prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bendahl, Pär-Ola, Belting, Mattias, Gezelius, Emelie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295929/
https://www.ncbi.nlm.nih.gov/pubmed/37370786
http://dx.doi.org/10.3390/cancers15123176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295929/
https://www.ncbi.nlm.nih.gov/pubmed/37370786
http://dx.doi.org/10.3390/cancers15123176

Ejemplares similares